Real-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.
Jose Maria Jimenez Alvir, DrPH
Advertisement
Articles by Jose Maria Jimenez Alvir, DrPH
Advertisement
Latest Updated Articles
- Real-world Usage of Bevacizumab-bvzr Biosimilar in US Oncology Practice
Published: February 9th 2022 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
2
Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing
3
FDA Approves Lumateperone as Add-On Therapy for Major Depressive Disorder
4
Preventing Tomorrow’s High-Cost Claims: The Rising-Risk Patient Opportunity in Medicaid
5
